CS logo
small CS logo
Istituto Dermopatico dell'Immacolata - IDI - IRCCS

Roma, Italy
Urgent care center in Rome
Via dei Monti di Creta, 104, 00167 Roma RM

About Istituto Dermopatico dell'Immacolata - IDI - IRCCS


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Amryt Research Limited
1
Daiichi Sankyo, Inc.
1
European Organisation for Research and Treatment of Cancer - EORTC
1
Fondazione Melanoma Onlus
1
Genta Incorporated
1
Janssen-Cilag S.p.A.
1
Sanofi
1
Stiefel, a GSK Company
1
Total Rows: 9

Clinical Trials at Istituto Dermopatico dell'Immacolata - IDI - IRCCS


During the past decade, Istituto Dermopatico dell'Immacolata - IDI - IRCCS conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years221111110011000011111100Started TrialsCompleted Trails2015201620172018201920200123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar Ichthyosis
2006-01-01
2007-04-01
Completed
98
Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease
2002-03-01
2005-04-01
Completed
125
Trial of Dacarbazine With or Without Genasense in Advanced Melanoma
2007-07-01
2011-05-01
Completed
300
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
2011-07-01
2017-06-14
Completed
1,232
Adjuvant PEG Intron in Ulcerated Melanoma
2012-10-01
2019-04-01
Unknown status
1,200
A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma
2012-09-24
2018-07-13
Completed
498
Sequential Combo Immuno and Target Therapy (SECOMBIT) Study
2016-11-14
2024-05-31
Active, not recruiting
251

Rows per page:

1–13 of 13

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Istituto Dermopatico dell'Immacolata - IDI - IRCCS" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Amryt Research Limited" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored and "Fondazione Melanoma Onlus" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Dermopatico dell'Immacolata - IDI - IRCCS" #1 collaborator was "Clinical Research Technology S.r.l." with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 5Hoffmann-La Roche: 5Amryt Research Limited: 1Amryt Research Limited: 1Daiichi Sankyo, Inc.: 1Daiichi Sankyo, Inc.: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1Fondazione Melanoma Onlus: 1Fondazione Melanoma Onlus: 1Genta Incorporated: 1Genta Incorporated: 1Janssen-Cilag S.p.A.: 1Janssen-Cilag S.p.A.: 1Sanofi: 1Sanofi: 1Stiefel, a GSK Company: 1Stiefel, a GSK Company: 1

Created with Highcharts 11.1.0Top CollaboratorsClinical ResearchTechnology S.r.l.: 1Clinical ResearchTechnology S.r.l.: 1NCIC Clinical Trials Group: 1NCIC Clinical Trials Group: 1

Clinical Trials Conditions at Istituto Dermopatico dell'Immacolata - IDI - IRCCS


According to Clinical.Site data, the most researched conditions in "Istituto Dermopatico dell'Immacolata - IDI - IRCCS" are "Melanoma" (2 trials), "Metastatic Melanoma" (2 trials), "Atrial Fibrillation" (1 trials), "Basal Cell Carcinoma" (1 trials) and "Epidermolysis Bullosa" (1 trials). Many other conditions were trialed in "Istituto Dermopatico dell'Immacolata - IDI - IRCCS" in a lesser frequency.

Clinical Trials Intervention Types at Istituto Dermopatico dell'Immacolata - IDI - IRCCS


Most popular intervention types in "Istituto Dermopatico dell'Immacolata - IDI - IRCCS" are "Drug" (11 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Vemurafenib" (3 trials), "Atezolizumab" (1 trials), "Cobimetinib" (1 trials), "Control gel" (1 trials) and "Edoxaban" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Istituto Dermopatico dell'Immacolata - IDI - IRCCS


The vast majority of trials in "Istituto Dermopatico dell'Immacolata - IDI - IRCCS" are 13 trials for "All" genders.

Clinical Trials Status at Istituto Dermopatico dell'Immacolata - IDI - IRCCS


Currently, there are NaN active trials in "Istituto Dermopatico dell'Immacolata - IDI - IRCCS". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Istituto Dermopatico dell'Immacolata - IDI - IRCCS, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Istituto Dermopatico dell'Immacolata - IDI - IRCCS, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Phase 2: 5Phase 2: 5

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Active, not recruiting: 2Active, not recruiting: 2Recruiting: 1Recruiting: 1Unknown status: 1Unknown status: 1